secwatch.observer — SEC 8-K summary
======================================

Issuer:     MYOMO, INC. (MYO)
CIK:        0001369290
Form:       8-K
Filed at:   2024-03-01T23:59:59+00:00
Accession:  0000950170-24-023543
Event type: regulatory
Sentiment:  positive
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CMS finalizes Medicare fee schedule for Myomo's MyoPro at $33,481-$65,872 per device
--------------------------------------------------------------------------------

- CMS final fee schedule rates: L8701 (Motion W) $33,480.90, L8702 (Motion G) $65,871.74, effective April 1, 2024.
- MyoPro classified as brace benefit category on Jan 1, 2024, enabling lump-sum reimbursement.
- CEO Paul Gudonis calls it 'important milestone' for Medicare Part B beneficiaries and the company.
- Process started in 2018 with HCPCS coding; now final rates enable billing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1369290/000095017024023543/0000950170-24-023543-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1369290/000095017024023543/myo-20240301.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-023543

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer